Cell line · CVCL_0131
A-172
Cancer cell line, Homo sapiens. Glioblastoma. 107 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. A-172. Cell lines, record CVCL_0131. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0131
On this page
Cell line
As Cellosaurus gives it.
- Name
- A-172
- Accession
- CVCL_0131
- RRID
- RRID:CVCL_0131
- Synonyms
- A172, A 172, A-172 MG, A-172MG
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 53Y
- Category
- Cancer cell line
- Diseases
- Glioblastoma (NCIt C3058); Glioblastoma (ORDO Orphanet_360)
- Derived from
- Brain (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers107
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Genetically engineered RNA inducers of proximity for protein regulation. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeted degradation of P-TEFb via MDM2 substrate substitution collapses oncogenic transcriptional programs in MDM2-amplified cancers. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for TMEM175 (UniProt ID: Q9BSA9) for use in western blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CUDC-907 inhibits glioblastoma and enhances glioblastoma sensitivity to temozolomide by inhibiting DNA damage repair. | Genes Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| B7 homolog 3-targeted CAR-T cells secreting EGFR T-cell engagers for improved control of glioblastoma progression. | Mol Biomed | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species. | Nat Methods | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spirohydantoin derivatives exert dopamine D2-like receptor-independent cytotoxicity in glioblastoma cells with possible involvement of calpain inhibition. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Machine learning model on multi-omics data enables risk stratification and identifies molecular heterogeneity and therapeutic targets in glioblastoma. | Mol Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ferroptosis resistance-related TEP1 as a novel prognostic biomarker involved in immune cell infiltration and tumour progression in glioblastoma. | Cancer Cell Int | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Mitochondrial connexin 43 modulates metabolic stress adaptation in glioma cell lines. | Cell Commun Signal | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 107
See all 107 papersRelatives6
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | A-172 EMC10 isoform HSS1 | CVCL_F1JP | Cell lines | |
| Derived from it | A-172 neo | CVCL_F1JQ | Cell lines | |
| Derived from it | A172/TMZ | CVCL_D5ZN | Cell lines | |
| Derived from it | D-54MG | CVCL_5735 | Has a recorded problem | Cell lines |
| Derived from it | HyCyte A-172 KO-hTP53 | CVCL_D6AE | Cell lines | |
| Derived from it | HyCyte A-172-Luc | CVCL_E3GJ | Cell lines |
Cell banks14
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1620 | ATCC | |
| ATCC | CRL-7899 | Discontinued | Cellosaurus |
| AddexBio | C0005009/5018 | Cellosaurus | |
| CLS | 300108 | CLS | |
| ECACC | 88062428 | ECACC | |
| Hysigen | TCH-C111 | Hysigen | |
| ICLC | HTL97013 | ICLC | |
| IZSLER | BS TCL 2 | Cellosaurus | |
| JCRB | JCRB0228 | JCRB | |
| KCB | KCB 200966YJ | Cellosaurus |
1 to 10 of 14
See all 14 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0131
GET https://conductscience.org/api/cell-lines/v1/CVCL_0131/papers?page=2